Stockholm, Sweden

ESTRO 2026

Session

Sunday
May 17
15:45 - 16:30
Poster Area
Radiomics, functional and biological imaging and outcome prediction
Poster Highlights
Physics
PISA (Pipeline for Interpretable-by-design Survival Analysis): A novel AI pipeline applied to survival prediction in patients with bone metastases
Thalea Schlender, The Netherlands
-513
Personalizing liver radiotherapy therapy through machine learning-based hypertrophy prediction models
Kristy Brock, USA
-3026
Assessing Transferability of Photon-derived NTCP Models in Predicting Radiation-Induced Optic Neuropathy After Proton Therapy
Juliette Thariat, France
-3042
MRI-based radiomic and clinical nomograms for personalized risk prediction in locally advanced cervical cancer treated with VMAT and MR-IGABT
Wiwatchai Sittiwong, Thailand
-3139
Daily MR-linac ADC measurements enable patient-specific uncertainty estimation of ADC changes during chemoradiation in esophageal cancer
Koen Kuijer, The Netherlands
-3351
Morphometric Analysis of Black Bone MRI: A Tool for Detection and Monitoring of Osteoradionecrosis Following Head and Neck Cancer Treatment
Natalie West, USA
-3408
Predicting high-grade glioma response: Comparing 1D, 2D, and 3D neural networks with a mechanistic model using a novel data assimilation pipeline.
Hugo Miniere, USA
-3505
A framework for modelling typical brain development as a baseline for post-treatment changes in children and young adults
Iolyn Chennell, United Kingdom
-3508
An MRI-based radiomic biomarker of radiosensitivity for individualized radiotherapy dose prescription in cervical cancer
Kohei Oguma, Japan
-3567
Can we use simulated contours to assess the reproducibility of radiomic features to interobserver contour variation?
Lois Holloway, Australia
-3604
Internal validation of a diffusion-MRI-based survival prediction model in pancreatic cancer: Results from a large validation cohort
Anne Bisgaard, Denmark
-3774
Is dose to large thoracic vessels a predictor of fatal bleeding after SBRT of central lung tumours? – An analysis of the expanded HILUS-cohort
Kristin Karlsson, Sweden
-1164
Multicentre validation confirms the superiority of advanced perfusion biomarkers over rCBV for relapse prediction in high-grade glioma
Camilla Satragno, France
-3975
Deep Learning scaling law in radiotherapy: outcome prediction performance vs dataset size
Miguel Garrett Fernandes, United Kingdom
-4000
Multi-sequence MRI-radiomics for non-invasive differentiation of tumour progression and radionecrosis in radiosurgery patients
Michael Maddalena, Canada
-4438
Limitations of CT-based radiomics when validated externally: Models trained on prostate cancer patients from 2 centres (N = 1298) for BCR prediction
Peter McHale, United Kingdom
-4523
Contrast enhanced CBCT capabilities of Halcyon with HyperSight: moving towards functional CBCT
Riley McMaster, Canada
-4621
Malignancy prediction through CT foundation model for lung lesions without pathologic confirmation
Arturo Navarro-Martin, Spain
-4744
Ensuring reliability of DW-MRI biomarkers : repeatability and reproducibility in pelvic organs on a 1.5 T MR-Linac
Madeline Michel, Belgium
-5127
Rethinking radionecrosis risk with a tissue-based dose–volume perspective beyond V12Gy
Szabolcs David, The Netherlands
-1173
Integrating Clinical, Radiomics, and Deep Learning Features for 12-Month Overall Survival Prediction in NSCLC Patients Treated with Radiotherapy
Jikai Zhou, The Netherlands
-1930
Development and Preliminary Evaluation of a Dosiomic Classifier for Early PSA Decay Kinetics after CyberKnife SBRT in Prostate Cancer
Rocco Mottareale, Italy
-2151
Proof of concept: synthetic FDG-PET generation from standard CT imaging for patients with head and neck cancer
Maksym Fritsak, Switzerland
-2760
Microstructural Parameters from Diffusion-Weighted MRI via Machine Learning and realistic in silico cellular models for Breast and Prostate Cancer
Chiara Tinelli, Italy
-2770
Radiomics and 4DCT phase analysis for predicting post-SBRT liver outcomes: a retrospective cohort study
Vitali Moiseenko, USA
-2911
Diffusion-MRI hypoxia mapping with distortion correction in head and neck cancer radiotherapy
Minoo Gandomi, Sweden
-3021